In summary, compared with normal renal tissues, most genes of the TGF-β pathway are significantly differentially expressed in ccRCC and can serve as risk or protective factors that affect the prognosis of patients with ccRCC. This evidence concerns the gene TGFB1 and nonpapillary renal cell carcinoma.